Correlation Between CBrain AS and ExpreS2ion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CBrain AS and ExpreS2ion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CBrain AS and ExpreS2ion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between cBrain AS and ExpreS2ion Biotech Holding, you can compare the effects of market volatilities on CBrain AS and ExpreS2ion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CBrain AS with a short position of ExpreS2ion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CBrain AS and ExpreS2ion Biotech.

Diversification Opportunities for CBrain AS and ExpreS2ion Biotech

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between CBrain and ExpreS2ion is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding cBrain AS and ExpreS2ion Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ExpreS2ion Biotech and CBrain AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on cBrain AS are associated (or correlated) with ExpreS2ion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ExpreS2ion Biotech has no effect on the direction of CBrain AS i.e., CBrain AS and ExpreS2ion Biotech go up and down completely randomly.

Pair Corralation between CBrain AS and ExpreS2ion Biotech

Assuming the 90 days trading horizon cBrain AS is expected to generate 0.36 times more return on investment than ExpreS2ion Biotech. However, cBrain AS is 2.79 times less risky than ExpreS2ion Biotech. It trades about 0.04 of its potential returns per unit of risk. ExpreS2ion Biotech Holding is currently generating about -0.11 per unit of risk. If you would invest  19,700  in cBrain AS on August 31, 2024 and sell it today you would earn a total of  1,000.00  from holding cBrain AS or generate 5.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

cBrain AS  vs.  ExpreS2ion Biotech Holding

 Performance 
       Timeline  
cBrain AS 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in cBrain AS are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, CBrain AS may actually be approaching a critical reversion point that can send shares even higher in December 2024.
ExpreS2ion Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ExpreS2ion Biotech Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

CBrain AS and ExpreS2ion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CBrain AS and ExpreS2ion Biotech

The main advantage of trading using opposite CBrain AS and ExpreS2ion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CBrain AS position performs unexpectedly, ExpreS2ion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will offset losses from the drop in ExpreS2ion Biotech's long position.
The idea behind cBrain AS and ExpreS2ion Biotech Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
CEOs Directory
Screen CEOs from public companies around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Insider Screener
Find insiders across different sectors to evaluate their impact on performance